Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - LONG-TERM DEBT
Long-term Debt MRSN - Mersana Therapeutics, Inc.
28.4 M
LAST VALUE
-11.10%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR